Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Comments
Loading...

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • PTC Therapeutics, Inc. PTCT shares dipped 21.3% to $46.00 in pre-market trading after the company announced its MOVE-FA trial of vatiquinone did not meet its primary endpoint. The company will discontinue its preclinical and early research gene therapy programs.
  • Global Net Lease, Inc. GNL shares fell 10.4% to $9.46 in pre-market trading. Global Net Lease is scheduled to host a webcast and conference call on May 24, 2023 at 11:00am ET to discuss its merger with The Necessity Retail REIT, Inc. Global Net Lease recently posted a decline in quarterly sales.
  • Agilent Technologies, Inc. A shares declined 8.8% to $117.30 in pre-market trading after the company cut its FY23 revenue outlook.
  • Apollomics, Inc. APLM shares dropped 8% to $3.80 in pre-market trading.
  • Genesis Growth Tech Acquisition Corp. GGAA shares fell 4.9% to $10.93 in pre-market trading after gaining 7% on Tuesday.
  • MorphoSys AG MOR shares dropped 4.4% to $6.14 in pre-market trading. MorphoSys recently reported better-than-expected quarterly results.
  • Prudential plc PUK shares dropped 3% to $27.91 in pre-market trading.

 

 

Now Read This: Analog Devices, Nvidia And 3 Stocks To Watch Heading Into Wednesday

Don’t forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!